These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22658528)

  • 1. Response trajectories in "real-world" naturalistically treated schizophrenia patients.
    Schennach R; Meyer S; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Musil R; Möller HJ; Riedel M
    Schizophr Res; 2012 Aug; 139(1-3):218-24. PubMed ID: 22658528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
    Schennach-Wolff R; Meyer S; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    J Psychiatr Res; 2011 Dec; 45(12):1639-47. PubMed ID: 21862035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials.
    Stauffer V; Case M; Kollack-Walker S; Ascher-Svanum H; Ball T; Kapur S; Kinon BJ
    Schizophr Res; 2011 Aug; 130(1-3):11-9. PubMed ID: 21489754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ; Rabinowitz J
    Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study.
    Levine SZ; Rabinowitz J; Case M; Ascher-Svanum H
    J Clin Psychopharmacol; 2010 Aug; 30(4):446-9. PubMed ID: 20631562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial.
    Levine SZ; Rabinowitz J; Faries D; Lawson AH; Ascher-Svanum H
    Schizophr Res; 2012 May; 137(1-3):141-6. PubMed ID: 22316567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
    Chou YH; Chiu NM; Yang TT; Feng J; Chan CC; Lee HK;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):255-60. PubMed ID: 23820333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study.
    Nordon C; Rouillon F; Azorin JM; Barry C; Urbach M; Falissard B
    Acta Psychiatr Scand; 2014 Feb; 129(2):116-25. PubMed ID: 23600715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
    Jäger M; Riedel M; Obermeier M; Schennach-Wolff R; Seemüller F; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Bottlender R; Möller HJ
    Schizophr Res; 2010 May; 118(1-3):183-8. PubMed ID: 20181461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia.
    Vita A; Deste G; De Peri L; Barlati S; Poli R; Cesana BM; Sacchetti E
    Schizophr Res; 2013 Oct; 150(1):51-7. PubMed ID: 23998953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.
    Docherty JP; Baker RA; Eudicone J; Mathew S; Marcus RN; McQuade RD; Mankoski R
    Schizophr Res; 2010 Jul; 120(1-3):199-203. PubMed ID: 20547037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories.
    Levine SZ; Leucht S
    Biol Psychiatry; 2010 Jul; 68(1):86-92. PubMed ID: 20227681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.
    Jaeger S; Pfiffner C; Weiser P; Kilian R; Becker T; Längle G; Eschweiler GW; Croissant D; Schepp W; Steinert T
    Psychiatry Res; 2012 Dec; 200(2-3):83-8. PubMed ID: 22534500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia.
    Potkin S; Agid O; Siu C; Watsky E; Vanderburg D; Remington G
    Schizophr Res; 2011 Nov; 132(2-3):108-13. PubMed ID: 21873032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of psychopathological course trajectories in schizophrenia.
    Jäger M; Weiser P; Becker T; Frasch K; Längle G; Croissant D; Steinert T; Jaeger S; Kilian R
    Psychiatry Res; 2014 Feb; 215(2):274-9. PubMed ID: 24374114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.